Your browser doesn't support javascript.
loading
Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton-Pump Inhibitors.
Sharma, Shringi; Pepin, Xavier; Burri, Harini; Zheng, Lianqing; Kuptsova-Clarkson, Nataliya; de Jong, Anouk; Yu, Ting; MacArthur, Holly L; Majewski, Michal; Byrd, John C; Furman, Richard R; Ware, Joseph A; Mann, James; Ramies, David; Munugalavadla, Veerendra; Sheridan, Louise; Tomkinson, Helen.
Afiliación
  • Sharma S; AstraZeneca, South San Francisco, California, USA.
  • Pepin X; New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, England, UK.
  • Burri H; AstraZeneca, South San Francisco, California, USA.
  • Zheng L; AstraZeneca, South San Francisco, California, USA.
  • Kuptsova-Clarkson N; AstraZeneca, Gaithersburg, Maryland, USA.
  • de Jong A; Acerta Pharma B.V., Oss, The Netherlands.
  • Yu T; AstraZeneca, South San Francisco, California, USA.
  • MacArthur HL; AstraZeneca, Mississauga, Ontario, Canada.
  • Majewski M; AstraZeneca, Mississauga, Ontario, Canada.
  • Byrd JC; Department of Internal Medicine and University of Cincinnati Cancer Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Furman RR; New York-Presbyterian/Weill Cornell Medicine, New York, New York, USA.
  • Ware JA; AstraZeneca, South San Francisco, California, USA.
  • Mann J; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, England, UK.
  • Ramies D; AstraZeneca, South San Francisco, California, USA.
  • Munugalavadla V; AstraZeneca, South San Francisco, California, USA.
  • Sheridan L; Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, England, UK.
  • Tomkinson H; AstraZeneca, Cambridge, England, UK.
Clin Pharmacol Drug Dev ; 11(11): 1294-1307, 2022 11.
Article en En | MEDLINE | ID: mdl-36029150

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirazinas / Inhibidores de la Bomba de Protones Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirazinas / Inhibidores de la Bomba de Protones Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2022 Tipo del documento: Article